These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 10738697)

  • 1. Immune response with biodegradable nanospheres and alum: studies in rabbits using staphylococcal enterotoxin B-toxoid.
    Desai MP; Hilfinger JM; Amidon GL; Levy RJ; Labhasetwar V
    J Microencapsul; 2000; 17(2):215-25. PubMed ID: 10738697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biodegradable and biocompatible poly(DL-lactide-co-glycolide) microspheres as an adjuvant for staphylococcal enterotoxin B toxoid which enhances the level of toxin-neutralizing antibodies.
    Eldridge JH; Staas JK; Meulbroek JA; Tice TR; Gilley RM
    Infect Immun; 1991 Sep; 59(9):2978-86. PubMed ID: 1879922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced immune response with a combination of alum and biodegradable nanoparticles containing tetanus toxoid.
    Raghuvanshi RJ; Mistra A; Talwar GP; Levy RJ; Labhasetwar V
    J Microencapsul; 2001; 18(6):723-32. PubMed ID: 11695637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dextran microspheres could enhance immune responses against PLGA nanospheres encapsulated with tetanus toxoid and Quillaja saponins after nasal immunization in rabbit.
    Mohaghegh M; Tafaghodi M
    Pharm Dev Technol; 2011 Feb; 16(1):36-43. PubMed ID: 20082579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intranasal and intramuscular proteosome-staphylococcal enterotoxin B (SEB) toxoid vaccines: immunogenicity and efficacy against lethal SEB intoxication in mice.
    Lowell GH; Kaminski RW; Grate S; Hunt RE; Charney C; Zimmer S; Colleton C
    Infect Immun; 1996 May; 64(5):1706-13. PubMed ID: 8613381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoadjuvant potential of cross-linked dextran microspheres mixed with chitosan nanospheres encapsulated with tetanus toxoid.
    Pirouzmand H; Khameneh B; Tafaghodi M
    Pharm Biol; 2017 Dec; 55(1):212-217. PubMed ID: 27927058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenicity and efficacy against lethal aerosol staphylococcal enterotoxin B challenge in monkeys by intramuscular and respiratory delivery of proteosome-toxoid vaccines.
    Lowell GH; Colleton C; Frost D; Kaminski RW; Hughes M; Hatch J; Hooper C; Estep J; Pitt L; Topper M; Hunt RE; Baker W; Baze WB
    Infect Immun; 1996 Nov; 64(11):4686-93. PubMed ID: 8890226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved immune response from biodegradable polymer particles entrapping tetanus toxoid by use of different immunization protocol and adjuvants.
    Raghuvanshi RS; Katare YK; Lalwani K; Ali MM; Singh O; Panda AK
    Int J Pharm; 2002 Oct; 245(1-2):109-21. PubMed ID: 12270248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of particle size, antigen load, dose and additional adjuvant on the immune response from antigen loaded PLA microparticles.
    Katare YK; Muthukumaran T; Panda AK
    Int J Pharm; 2005 Sep; 301(1-2):149-60. PubMed ID: 16023313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune response after oral administration of the encapsulated malaria synthetic peptide SPf66.
    Carcaboso AM; Hernández RM; Igartua M; Gascón AR; Rosas JE; Patarroyo ME; Pedraz JL
    Int J Pharm; 2003 Jul; 260(2):273-82. PubMed ID: 12842346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis B Antigen Loaded Biodegradable Polymeric Nanoparticles: Formulation Optimization and In-vivo Immunization in BALB/c Mice.
    Dewangan HK; Singh S; Maurya L; Srivastava A
    Curr Drug Deliv; 2018; 15(8):1204-1215. PubMed ID: 29866006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenicity and lower dose requirement of polymer entrapped tetanus toxoid co-administered with alum.
    Katare YK; Panda AK
    Vaccine; 2006 Apr; 24(17):3599-608. PubMed ID: 16513224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Particle size studies for subcutaneous delivery of poly(lactide-co-glycolide) microspheres containing ovalbumin as vaccine formulation.
    Uchida T; Goto S; Foster TP
    J Pharm Pharmacol; 1995 Jul; 47(7):556-60. PubMed ID: 8568620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of immune responses by co-delivery of a CpG oligodeoxynucleotide and tetanus toxoid in biodegradable nanospheres.
    Diwan M; Tafaghodi M; Samuel J
    J Control Release; 2002 Dec; 85(1-3):247-62. PubMed ID: 12480329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of systemic and mucosal immune responses by intranasal administration of alginate microspheres encapsulated with tetanus toxoid and CpG-ODN.
    Tafaghodi M; Sajadi Tabassi SA; Jaafari MR
    Int J Pharm; 2006 Aug; 319(1-2):37-43. PubMed ID: 16701972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. c-di-GMP as a vaccine adjuvant enhances protection against systemic methicillin-resistant Staphylococcus aureus (MRSA) infection.
    Hu DL; Narita K; Hyodo M; Hayakawa Y; Nakane A; Karaolis DK
    Vaccine; 2009 Jul; 27(35):4867-73. PubMed ID: 19406185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced immune response after subcutaneous and oral immunization with biodegradable PLGA microspheres.
    Igartua M; Hernández RM; Esquisabel A; Gascón AR; Calvo MB; Pedraz JL
    J Control Release; 1998 Dec; 56(1-3):63-73. PubMed ID: 9801430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccine-containing biodegradable microspheres specifically enter the gut-associated lymphoid tissue following oral administration and induce a disseminated mucosal immune response.
    Eldridge JH; Meulbroek JA; Staas JK; Tice TR; Gilley RM
    Adv Exp Med Biol; 1989; 251():191-202. PubMed ID: 2610110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of humoral and cell-mediated immune responses to cationic PLGA microspheres containing recombinant hepatitis B antigen.
    Saini V; Jain V; Sudheesh MS; Jaganathan KS; Murthy PK; Kohli DV
    Int J Pharm; 2011 Apr; 408(1-2):50-7. PubMed ID: 21291968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunization against leishmaniasis by PLGA nanospheres loaded with an experimental autoclaved Leishmania major (ALM) and Quillaja saponins.
    Tafaghodi M; Eskandari M; Kharazizadeh M; Khamesipour A; Jaafari MR
    Trop Biomed; 2010 Dec; 27(3):639-50. PubMed ID: 21399606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.